193 related articles for article (PubMed ID: 37889215)
1. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study.
Rozental AJ; Weisbeck BG; Corsato Alvarenga I; Gustafson DL; Kusick BR; Rao S; Bartner LR; McGrath S
J Vet Intern Med; 2023; 37(6):2291-2300. PubMed ID: 37889215
[TBL] [Abstract][Full Text] [Related]
2. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
3. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy.
McGrath S; Bartner LR; Rao S; Packer RA; Gustafson DL
J Am Vet Med Assoc; 2019 Jun; 254(11):1301-1308. PubMed ID: 31067185
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol in canine epilepsy.
Potschka H; Bhatti SFM; Tipold A; McGrath S
Vet J; 2022 Dec; 290():105913. PubMed ID: 36209995
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
Lattanzi S; Brigo F; Trinka E; Zaccara G; Cagnetti C; Del Giovane C; Silvestrini M
Drugs; 2018 Nov; 78(17):1791-1804. PubMed ID: 30390221
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
[TBL] [Abstract][Full Text] [Related]
7. A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.
Berk BA; Law TH; Packer RMA; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Meads Z; Volk HA
J Vet Intern Med; 2020 May; 34(3):1248-1259. PubMed ID: 32293065
[TBL] [Abstract][Full Text] [Related]
8. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial.
O'Brien TJ; Berkovic SF; French JA; Messenheimer JA; Sebree TB; Bonn-Miller MO; Gutterman DL;
JAMA Netw Open; 2022 Jul; 5(7):e2220189. PubMed ID: 35802375
[TBL] [Abstract][Full Text] [Related]
11. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O; Cross JH; Laux L; Marsh E; Miller I; Nabbout R; Scheffer IE; Thiele EA; Wright S;
N Engl J Med; 2017 May; 376(21):2011-2020. PubMed ID: 28538134
[TBL] [Abstract][Full Text] [Related]
12. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6.
Wu JY; Cock HR; Devinsky O; Joshi C; Miller I; Roberts CM; Sanchez-Carpintero R; Checketts D; Sahebkar F
Epilepsia; 2022 May; 63(5):1189-1199. PubMed ID: 35175622
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.
Park YD; Linder DF; Pope J; Flamini JR; Moretz K; Diamond MP; Long SA
Epilepsy Behav; 2020 Nov; 112():107474. PubMed ID: 33181893
[TBL] [Abstract][Full Text] [Related]
14. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Devinsky O; Patel AD; Cross JH; Villanueva V; Wirrell EC; Privitera M; Greenwood SM; Roberts C; Checketts D; VanLandingham KE; Zuberi SM;
N Engl J Med; 2018 May; 378(20):1888-1897. PubMed ID: 29768152
[TBL] [Abstract][Full Text] [Related]
16. Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
Thiele EA; Bebin EM; Bhathal H; Jansen FE; Kotulska K; Lawson JA; O'Callaghan FJ; Wong M; Sahebkar F; Checketts D; Knappertz V;
JAMA Neurol; 2021 Mar; 78(3):285-292. PubMed ID: 33346789
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
18. Partial protective effects of cannabidiol against PTZ-induced acute seizures in female rats during the proestrus-estrus transition.
Janisset NRLL; Romariz SAA; Hashiguchi D; Quintella ML; Gimenes C; Yokoyama T; Filev R; Carlini E; Barbosa da Silva R; Faber J; Longo BM
Epilepsy Behav; 2022 Apr; 129():108615. PubMed ID: 35217387
[TBL] [Abstract][Full Text] [Related]
19. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V;
JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035
[TBL] [Abstract][Full Text] [Related]
20. Efficacy evaluation of a commercially available MCT enriched therapeutic diet on dogs with idiopathic epilepsy treated with zonisamide: a prospective, randomized, double-blinded, placebo-controlled, crossover dietary preliminary study.
Nakatsuka K; Zanghi B; Hasegawa D
BMC Vet Res; 2023 Sep; 19(1):145. PubMed ID: 37674206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
